Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Loupy

Showing results (61-70 of 206) with videos related to

Pageof 21
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 1, 2017
T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allograftsCarmen Lefaucheur, Clément Gosset, Marion Rabant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 25, 2023
Banff Human Organ Transplant Consensus Gene Panel for the Detection of Antibody Mediated Rejection in Heart Allograft BiopsiesAlessia Giarraputo, Guillaume Coutance, Olivier Aubert, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 14, 2024
Estimating the efficacy of felzartamab to treat antibody-mediated rejection using the iBox prognostication systemYannis Lombardi, Marc Raynaud, Martina Schatzl, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 24, 2024
Long-Term Outcomes after Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant RecipientsGillian Divard, Olivier Aubert, Charlotte Debiais-Deschamp, et al.
Kidney International|May 27, 2018
Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejectionDenis Viglietti, Yassine Bouatou, Vissal David Kheav, et al.
Circulation Research|June 10, 2015
Determinants and Outcomes of Accelerated Arteriosclerosis: Major Impact of Circulating AntibodiesAlexandre Loupy, Dewi Vernerey, Denis Viglietti, et al.
Kidney International|May 31, 2017
Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosisClément Gosset, Denis Viglietti, Marion Rabant, et al.
Transplantation|April 9, 2025
Donor-derived Cell-free DNA as a Noninvasive Biomarker of Kidney Allograft Rejection in Pediatric Kidney TransplantationJulien Hogan, Roshan George, Carissa Hayes, et al.
Journal of the American Society of Nephrology : JASN|March 4, 2017
Antibody-Mediated Rejection Due to Preexisting versus <i>De Novo</i> Donor-Specific Antibodies in Kidney Allograft RecipientsOlivier Aubert, Alexandre Loupy, Luis Hidalgo, et al.
Transplantation|September 16, 2014
Kidney allograft fibrosis after transplantation from uncontrolled circulatory death donorsDenis Viglietti, Imad Abboud, Gary Hill, et al.
Pageof 21

Showing results (61-70 of 206) with videos related to

Sort By:
Pageof 21
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 1, 2017
T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allograftsCarmen Lefaucheur, Clément Gosset, Marion Rabant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 25, 2023
Banff Human Organ Transplant Consensus Gene Panel for the Detection of Antibody Mediated Rejection in Heart Allograft BiopsiesAlessia Giarraputo, Guillaume Coutance, Olivier Aubert, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 14, 2024
Estimating the efficacy of felzartamab to treat antibody-mediated rejection using the iBox prognostication systemYannis Lombardi, Marc Raynaud, Martina Schatzl, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 24, 2024
Long-Term Outcomes after Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant RecipientsGillian Divard, Olivier Aubert, Charlotte Debiais-Deschamp, et al.
Kidney International|May 27, 2018
Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejectionDenis Viglietti, Yassine Bouatou, Vissal David Kheav, et al.
Circulation Research|June 10, 2015
Determinants and Outcomes of Accelerated Arteriosclerosis: Major Impact of Circulating AntibodiesAlexandre Loupy, Dewi Vernerey, Denis Viglietti, et al.
Kidney International|May 31, 2017
Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosisClément Gosset, Denis Viglietti, Marion Rabant, et al.
Transplantation|April 9, 2025
Donor-derived Cell-free DNA as a Noninvasive Biomarker of Kidney Allograft Rejection in Pediatric Kidney TransplantationJulien Hogan, Roshan George, Carissa Hayes, et al.
Journal of the American Society of Nephrology : JASN|March 4, 2017
Antibody-Mediated Rejection Due to Preexisting versus <i>De Novo</i> Donor-Specific Antibodies in Kidney Allograft RecipientsOlivier Aubert, Alexandre Loupy, Luis Hidalgo, et al.
Transplantation|September 16, 2014
Kidney allograft fibrosis after transplantation from uncontrolled circulatory death donorsDenis Viglietti, Imad Abboud, Gary Hill, et al.
Pageof 21